Related content

Immunosuppressive Treatment in C3 Glomerulopathy: Is it Really Effective?

By  

American Journal of Nephrology, Vol. 46, Iss. 2, 2017-07 ,pp. : 96-107

Karger

Access to resources Recommend Favorite

Association of a Novel 3-Amino Acid Deletion Mutation of Apolipoprotein E (Apo E Tokyo) with Lipoprotein Glomerulopathy

By  

Nephron, Vol. 83, Iss. 3, 1999-10 ,pp. : 214-218

Karger

Access to resources Recommend Favorite

A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate

By  

Case Reports in Nephrology and Dialysis, Vol. 7, Iss. 2, 2017-07 ,pp. : 112-120

Karger

Access to resources Recommend Favorite

Second-Line Immunosuppressive Treatment of Childhood Nephrotic Syndrome: A Single-Center Experience

By  

Nephron Extra, Vol. 4, Iss. 1, 2014-01 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

New Cases of Lipoprotein Glomerulopathy?

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 557-559

Karger

Access to resources Recommend Favorite